# Conversion Labs, Inc. (CVLB)

Source: https://www.quantisnow.com/company/CVLB
Generated: 2026-11-13T03:52:51.670Z

- Ticker: CVLB
- Exchange: NASDAQ
- Sector: n/a
- Industry: n/a
- IPO year: n/a

## Latest CVLB news and filings

- 2021-03-19 20:15 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Conversion Labs, Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-conversion-labs-inc-532033)
- 2021-02-26 22:00 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-447839)
- 2021-02-26 15:04 UTC [SEC Form 4] [SEC Form 4: David Happy Walters was granted 1,200,000 units of Common Stock, increasing ownership by 149% to 1,336,300 units](https://www.quantisnow.com/insight/sec-form-4-david-happy-walters-was-granted-1200000-units-445603)
- 2021-02-26 00:16 UTC [SEC Form 4] [SEC Form 4: Harold Eric Yecies bought $100,400 worth of Common Stock (5,000 units at $20.08)](https://www.quantisnow.com/insight/sec-form-4-harold-eric-yecies-bought-100400-worth-of-443341)
- 2021-02-25 23:13 UTC [SEC Form 4] [SEC Form 4: Michael Brad Roberts bought $102,500 worth of Common Stock (5,000 units at $20.50)](https://www.quantisnow.com/insight/sec-form-4-michael-brad-roberts-bought-102500-worth-of-443166)
- 2021-02-22 12:30 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-417299)
- 2021-02-22 08:30 UTC [Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD ](https://www.quantisnow.com/insight/conversion-labs-begins-trading-under-new-company-name-lifemd-and-416589)
- 2021-02-18 14:19 UTC [Analyst Coverage Reiterated] [BTIG Research reiterated coverage on Conversion Labs with a new price target](https://www.quantisnow.com/insight/btig-research-reiterated-coverage-on-conversion-labs-with-a-new-409506)
- 2021-02-12 13:30 UTC [Conversion Labs to Become Life MD™ with Launch of New Concierge Telehealth Services](https://www.quantisnow.com/insight/conversion-labs-to-become-life-md-with-launch-of-new-387921)
- 2021-02-12 13:30 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-387892)
- 2021-02-10 21:00 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-378146)
- 2021-02-10 11:01 UTC [SEC Form 3] [SEC Form 3: David Marc Benathen claimed ownership of 15,000 units of Restricted Stock Units](https://www.quantisnow.com/insight/sec-form-3-david-marc-benathen-claimed-ownership-of-15000-372535)
- 2021-02-05 22:00 UTC [SEC Form 3] [SEC Form 3 filed by Corey Deutsch](https://www.quantisnow.com/insight/sec-form-3-filed-by-corey-deutsch-359440)
- 2021-02-05 13:31 UTC [Leadership Update] [Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer](https://www.quantisnow.com/insight/conversion-labs-appoints-seasoned-financial-and-operational-executive-marc-benathen-357461)
- 2021-02-05 11:59 UTC [Analyst Coverage Initiated] [B. Riley FBR initiated coverage on Conversion Labs with a new price target](https://www.quantisnow.com/insight/b-riley-fbr-initiated-coverage-on-conversion-labs-with-a-356799)
- 2021-02-04 22:00 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-355367)
- 2021-02-03 12:37 UTC [SEC Form 3] [SEC Form 3: Michael Brad Roberts claimed ownership of 10,000 units of Restricted Stock Units](https://www.quantisnow.com/insight/sec-form-3-michael-brad-roberts-claimed-ownership-of-10000-345767)
- 2021-02-02 19:55 UTC [SEC Form 4] [SEC Form 4: Justin Schreiber gifted 20,000 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-justin-schreiber-gifted-20000-units-of-common-342084)
- 2021-02-02 15:10 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-340794)
- 2021-01-28 22:30 UTC [SEC Form 8-K/A filed](https://www.quantisnow.com/insight/sec-form-8-ka-filed-327499)
- 2021-01-28 15:30 UTC [Conversion Labs Increases Stake in Fast-Growing SaaS Subsidiary](https://www.quantisnow.com/insight/conversion-labs-increases-stake-in-fast-growing-saas-subsidiary-325230)
- 2021-01-26 22:15 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-317737)
- 2021-01-19 21:15 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-295359)
- 2021-01-19 13:31 UTC [Conversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million](https://www.quantisnow.com/insight/conversion-labs-expects-2020-revenue-up-205-to-record-380-293104)
- 2021-01-15 21:21 UTC [SEC Form 3 filed by Ii David Anthony Puopolo](https://www.quantisnow.com/insight/sec-form-3-filed-by-ii-david-anthony-puopolo-289229)
- 2021-01-14 21:15 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-286189)
- 2021-01-14 21:15 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-286188)
- 2021-01-14 15:41 UTC [SEC Form 3 filed by Patrick Bryant Hussey](https://www.quantisnow.com/insight/sec-form-3-filed-by-patrick-bryant-hussey-285064)
- 2021-01-11 21:15 UTC [SEC Form 8-K filed](https://www.quantisnow.com/insight/sec-form-8-k-filed-274001)
- 2021-01-11 13:31 UTC [Leadership Update] [Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical Officer](https://www.quantisnow.com/insight/conversion-labs-appoints-leading-telehealth-professional-dr-anthony-puopolo-as-272181)
- 2021-01-06 21:01 UTC [Conference Announcement] [Conversion Labs to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021](https://www.quantisnow.com/insight/conversion-labs-to-present-at-the-hc-wainwright-virtual-bioconnect-262019)
- 2021-01-05 15:15 UTC [Leadership Update] [Conversion Labs Appoints Digital Marketing Executive, Bryant Hussey, as Chief Digital Officer](https://www.quantisnow.com/insight/conversion-labs-appoints-digital-marketing-executive-bryant-hussey-as-chief-254619)
- 2021-01-04 05:15 UTC [SEC Form EFFECT filed](https://www.quantisnow.com/insight/sec-form-effect-filed-248700)
- 2020-12-29 21:39 UTC [SEC Form S filed](https://www.quantisnow.com/insight/sec-form-s-filed-243383)
- 2020-12-28 22:10 UTC [SEC Form 8 filed](https://www.quantisnow.com/insight/sec-form-8-filed-241133)
- 2020-12-15 13:31 UTC [Conversion Labs Annualized Revenue Run-Rate Hits $53.9 Million, up 332% vs. 2019, Driven by Subscriptions to an Expanding Suite of Telehealth Brands](https://www.quantisnow.com/insight/conversion-labs-annualized-revenue-run-rate-hits-539-million-up-332-217087)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CVLB
- Earnings history: https://www.quantisnow.com/earnings/CVLB
- Dividend history: https://www.quantisnow.com/dividends/CVLB
- Insider transactions: https://www.quantisnow.com/insiders/CVLB
- Options chain: https://www.quantisnow.com/options/CVLB
- SEC 8-K filings only: https://www.quantisnow.com/company/CVLB/8-k
- RSS and alerts for CVLB: https://www.quantisnow.com/docs/rss-feeds.md